Daiwa Securities Group Inc. Recursion Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

$29.6 Billion
Q3 2025

A detailed history of Daiwa Securities Group Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 11,707 shares of RXRX stock, worth $48,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,707

Previous 12,706 7.86%

Holding current value

$48,466

Previous $64,000 10.94%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$4.52 - $6.54 $4,515 - $6,533	-999 Reduced 7.86%	11,707 $57,000
Q2 2025 Aug 14, 2025	BUY	$3.97 - $5.84 $11,445 - $16,836	2,883 Added 29.35%	12,706 $64,000
Q1 2025 May 13, 2025	SELL	$5.29 - $10.87 $1,650 - $3,391	-312 Reduced 3.08%	9,823 $52,000
Q4 2024 Feb 07, 2025	BUY	$5.7 - $8.27 $12,739 - $18,483	2,235 Added 28.29%	10,135 $69,000
Q3 2024 Nov 12, 2024	BUY	$5.92 - $8.6 $189 - $275	32 Added 0.41%	7,900 $52,000

Q2 2024 Aug 07, 2024	SELL	$7.35 - $10.05 $23,622 - $32,300	-3,214 Reduced 29.0%	7,868 $59,000
Q1 2024 May 02, 2024	SELL	$9.13 - $15.52 $6,181 - $10,507	-677 Reduced 5.76%	11,082 $110,000
Q4 2023 Jan 31, 2024	BUY	$5.09 - $10.79 $56,132 - $118,992	11,028 Added 1508.62%	11,759 $116,000
Q2 2023 Jul 31, 2023	SELL	$4.56 - $9.94 $35,020 - $76,339	-7,680 Reduced 91.31%	731 $5,000
Q1 2023 May 02, 2023	BUY	$6.42 - $9.64 $9,681 - $14,537	1,508 Added 21.85%	8,411 $56,000
Q4 2022 Feb 06, 2023	BUY	$7.16 - $12.7 $45,050 - $79,908	6,292 Added 1029.79%	6,903 $53,000
Q3 2022 Nov 02, 2022	SELL	$7.83 - $13.6 $90,702 - $157,542	-11,584 Reduced 94.99%	611 $7,000
Q2 2022 Aug 09, 2022	BUY	$5.04 - $9.26 $24,968 - $45,874	4,954 Added 68.42%	12,195 $99,000
Q1 2022 Apr 29, 2022	BUY	$6.16 - $18.03 $13,102 - $38,349	2,127 Added 41.59%	7,241 $52,000
Q4 2021 Feb 03, 2022	BUY	$16.14 - $21.86 $82,539 - $111,792	5,114 New	5,114 $88,000

Others Institutions Holding RXRX

# of Institutions

361

Shares Held

301M

Call Options Held

7.71M

Put Options Held

4.85M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $747M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Recursion Pharmaceuticals, Inc. Transaction History